INS and type 2 diabetes mellitus: A series of in vitro analyses have provided experimental evidence for the ability of HDL-C to prevent or reverse reductions in insulin secretion associated with exposure to oxidized LDL-C, and one randomized controlled trial found that recombinant HDL infusion promoted AMPK pathway activation in the skeletal muscle of individuals with T2DM [29, 30].